SCHEMBL4476336

SCHEMBL4476336

Cc1c(F)c(F)c(F)c(NC(=O)Nc2ccc(-c3c(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c[nH]c3C(N)=O)cc2)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 5/20 0.49
FLT3 P36888 5/20 0.49
AURKB Q96GD4 2/20 0.49
NTRK1 P04629 1/20 0.49
RET P07949 1/20 0.49
LTK P29376 1/20 0.49
CDK8 P49336 1/20 0.49
NTRK3 Q16288 1/20 0.49
MAPK14 Q16539 1/20 0.49
NTRK2 Q16620 1/20 0.49
KDR P35968 14/20 0.48
KIT P10721 5/20 0.48
FLT1 P17948 4/20 0.48
FLT4 P35916 3/20 0.48
TEK Q02763 3/20 0.48
LCK P06239 2/20 0.48
CSF1R P07333 2/20 0.48
AURKA O14965 1/20 0.48
FGFR1 P11362 1/20 0.48
PDGFRA P16234 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1923687 0.89 CA12 (0.57) PDGFRBFLT3AURKBNTRK1RET
SCHEMBL1923772 0.87 CA12 (0.53) PDGFRBFLT3AURKBNTRK1RET
SCHEMBL13790139 0.85 PDGFRB (0.58) PDGFRBFLT3AURKBNTRK1RET
SCHEMBL1923906 0.83 CA12 (0.54) PDGFRBFLT3AURKBNTRK1RET
SCHEMBL1923902 0.83 KDR (0.49) PDGFRBFLT3AURKBNTRK1RET
SCHEMBL1923742 0.83 KDR (0.58) PDGFRBFLT3AURKBNTRK1RET
SCHEMBL1924817 0.82 KDR (0.48) PDGFRBFLT3AURKBNTRK1RET
SCHEMBL1924576 0.82 CA12 (0.55) PDGFRBFLT3AURKBNTRK1RET
SCHEMBL1923690 0.82 CA12 (0.55) PDGFRBFLT3AURKBNTRK1RET
Hydrochloric Acid SCHEMBL1924264 0.81 CA12 (0.54) PDGFRBFLT3AURKBNTRK1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080045542-A1 Substituted Pyrroles and Imidazoles, Compositions Containing Same, Manufacturing Process Therefor and Use Thereof AVENTIS PHARMA S.A. (FR) 2008-02-21 US claimed
US-7560571-B2 Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof AVENTIS PHARMA S.A. (FR) 2009-07-14 US disclosed
US-20080045542-A1 Substituted Pyrroles and Imidazoles, Compositions Containing Same, Manufacturing Process Therefor and Use Thereof AVENTIS PHARMA S.A. (FR) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045542-A1 Substituted Pyrroles and Imidazoles, Compositions Containing Same, Manufacturing Process Therefor and Use Thereof WEE1, WEE2, FARS2 PDGFRB 1594/4885FLT3 132/4885AURKB 1611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.